|
|
|
|
 | | WATCHMAN device |
|  | | AF Is Associated with Serious Events Different Vascular Territories1 |
|
 | | Relative Risk Reduction of Stroke in Atrial Fibrillation |
|  | | Relative Risk Reduction of Stroke in Atrial Fibrillation |
|
 | | Relative Risk Reduction of Stroke in Atrial Fibrillation |
|  | | AF Investigators’ Collaborative Analysis |
|
 | | CHADS2 score |
|  | | Dia 12 |
|
|  | | Nieuwe antithrombotica bij boezemfibrilleren |
|
 | | farmacologie |
|
|
|  | | inclusion |
|
 | | exclusion |
|
|
 | | Dia 21 |
|
|
 | | Dia 23 |
|
|
 | | conclusions |
|
|
 | | RE-LY: A Non-inferiority Trial |
|  | | RE-LY primary outcome: stroke or systemic embolism |
|
 | | Stroke or Systemic Embolism |
|
|
|  | | RELY: Conclusions |
|
 | | Dia 33 |
|  | | Study Design |
|
 | | Primary Efficacy Outcome Stroke and non-CNS Embolism |
|  | | ROCKET |
|
 | | ROCKET Summary |
|  | | RE-LY: A Non-inferiority Trial |
|
 | | RE-LY primary outcome: stroke or systemic embolism |
|  | | Stroke or Systemic Embolism |
|
|
|
|  | | Event rates in VKA group% per year) |
|
 | | A comparison of risk reductions; point estimates and CI’s |
|  | | conclusies |
|
 | | problemen |
|  | | Gezondheidsraad 15 mei 2012 |
|
 | | Gezondheidsraad 15 mei 2012 |
|
Deel deze pagina met collega's en vrienden: